Sort
10,766 grants matching “checkpoint inhibitor”
A novel signaling mechanism for LRP5
$519,210Dianqing Wu · Yale University · R01 · FY2024 · CA
Systemic RNA Delivery to Tumors
$518,820Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2024 · CA
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
$518,698Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Microbiota-Immune Interactions in CTLA-4 Antibody Blockade-Induced Colitis
$518,680Gabriel Nunez · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Pro-tumorigenic functions of human DNA polymerases eta and kappa during genome duplication under physiological replication stress conditions
$518,614Kristin A Eckert · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · CA
Deciphering the Molecular Mechanisms Underlying Cholangiocarcinoma Development
$518,219Sungjin Ko · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
A New Immune Checkpoint Pathway in Human Bladder Cancer
$518,205Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
Myct1 control of the angioimmune interface
$518,199Kyunghee Choi · Washington University · R01 · FY2024 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$518,180Yong Wan · Emory University · R01 · FY2022 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$517,922Thomas G Graeber · University Of California Los Angeles · P01 · FY2020 · CA
Project 2: Targeting differentiation-linked redox sensitivity in melanoma
$517,922Thomas G Graeber · University Of California Los Angeles · P01 · FY2021 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$517,920Roger S Lo · University Of California Los Angeles · P01 · FY2021 · CA
Project 1: Strategies to enhance MEK inhibitor efficacy in MUTNRAS melanoma
$517,920Roger S Lo · University Of California Los Angeles · P01 · FY2020 · CA
An integrated polymeric carrier for subunit cancer vaccines
$517,545Suzie H Pun · University Of Washington · R01 · FY2025 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$517,415Justin M Balko · Vanderbilt University Medical Center · R01 · FY2021 · CA
Cooperation of Co-Amplified Genes in Hepatocellular Carcinoma
$517,389Devanand Sarkar · Virginia Commonwealth University · P01 · FY2025 · CA
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
$517,329Anton Wellstein · Georgetown University · R01 · FY2019 · CA
Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck Cancers
$517,263Wenbin Lin · University Of Chicago · R01 · FY2020 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$517,238Aleksander S. Popel · Johns Hopkins University · R01 · FY2022 · CA
Project 1
$517,215Ann G Schwartz · Wayne State University · P20 · FY2022 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$516,975Marco Ruella · University Of Pennsylvania · R37 · FY2023 · CA
Tissue Resident memory T cell responses to cancer
$516,944Mary J Turk · Dartmouth College · R01 · FY2019 · CA
Translational Immunology
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Rare Central Nervous System Cancers Initiative
$516,832Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$516,726Gordon B. Mills · Oregon Health & Science University · U01 · FY2023 · CA